2024
Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
MORAVCOVA, Katarina, Marketa SOVOVA, Jaromir OZANA, Martina KARBANOVÁ, Jan KLASEK et. al.Základní údaje
Originální název
Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
Autoři
MORAVCOVA, Katarina (203 Česká republika), Marketa SOVOVA (203 Česká republika), Jaromir OZANA (203 Česká republika), Martina KARBANOVÁ (203 Česká republika, domácí), Jan KLASEK (203 Česká republika), Agnieszka Barbara KOLASINSKA (203 Česká republika) a Eliska SOVOVA (203 Česká republika)
Vydání
Nutrients, Basel, MDPI, 2024, 2072-6643
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.900 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001231311000001
Klíčová slova anglicky
obesity; digital therapeutics; lifestyle intervention; diabetes mellitus type 2; insulin resistance
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 6. 2024 08:33, Mgr. Tereza Miškechová
Anotace
V originále
Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.